Cronos Group Inc. Files Proxy Statement Supplement

TL;DR

Cronos Group filed proxy docs, shareholders vote soon.

AI Summary

Cronos Group Inc. filed a Definitive Additional Materials proxy statement on July 5, 2024, related to its 2023 fiscal year. The filing concerns the company's proxy materials and is a supplement to its previous proxy statement. No fee was required for this filing.

Why It Matters

This filing provides updated or additional information to shareholders regarding the company's governance and voting matters, which is crucial for informed decision-making.

Risk Assessment

Risk Level: low — This is a routine proxy filing supplement with no immediate financial or operational risks indicated.

Key Players & Entities

• Cronos Group Inc. (company) — Registrant
• PharmaCan Capital Corp. (company) — Former company name

FAQ

From the Filing

0001656472-24-000079.txt : 20240705 0001656472-24-000079.hdr.sgml : 20240705 20240705163032 ACCESSION NUMBER: 0001656472-24-000079 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 12 FILED AS OF DATE: 20240705 DATE AS OF CHANGE: 20240705 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 241102879 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 DEFA14A 1 cron-20240705.htm DEFA14A cron-20240705 0001656472 DEFA14A FALSE 0001656472 2023-01-01 2023-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material under §240.14a-12 CRONOS GROUP INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): ☒ No fee required. ☐ Fee paid previously with preliminary materials. ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. SUPPLEMENT TO PROXY STATEMENT DATED APRIL 26, 2024 FOR THE 2024 ANNUAL MEETING OF SHAREHOLDERS This supplement (this “Supplement”) supplements the definitive proxy statement (the “Definitive Proxy Statement”) filed by Cronos Group Inc. (the “Company”) with the U.S. Securities and Exchange Commission (“SEC”) and on the Company’s profile on SEDAR+ at www.sedarplus.com on April 26, 2024 and made available to the holders (the “Shareholders”) of common shares (“Shares”) of the Company in connection with the 2024 Annual Meeting (the “Annual Meeting”), which meeting will be reconvened and held virtually on July 19, 2024. This Supplement is being filed with the SEC and on the Company’s profile on SEDAR+ at www.sedarplus.com and made available to stockholders on or about July 5, 2024. The purpose of this Supplement is to provide additional information related to (i) the reconvening of the Company’s Annual Meeting that was previously adjourned and (ii) the proposal to appoint the Company’s independent registered public accounting firm to serve as the Company’s independent auditor for the fiscal year ending December 31, 2024 and to authorize the Board of Directors (the “Board”) to fix the independent auditor’s remuneration. Accordingly, the information set forth under “Supplement to Proposal No. 3—Appointment of Independent Auditor” below supplements the disclosures under the heading “Proposal No. 3—Appointment of Independent Auditor” beginning on page 56 of the Definitive Proxy Statement. SUPPLEMENT TO PROPOSAL NO. 3—APPOINTMENT OF INDEPENDENT AUDITOR The Audit Committee of the Board (the “Audit Committee”) has recommended to the Board that Davidson & Company LLP (“Davidson & Company”) be nominated for appointment by the Shareholders as the Company’s independent auditor for the fiscal year ending D